Gossamer Bio GOSS
NASDAQ GOSS
$0.15 0.00 (-1.78%)
At close: Aug 21, 2026 · 4:00 PM EDT

Gossamer Bio (GOSS) Amortizatization of Intangibles (2019 - 2026)

Gossamer Bio (GOSS) posted quarterly Amortizatization of Intangibles of $660000.0 for Q1 2026, down 75.25% year-over-year from $2.7 million in Q1 2025, and down 39.0% quarter-over-quarter from $1.1 million in Q4 2025.

Gossamer Bio (GOSS) Amortizatization of Intangibles (2019 - 2026) Analysis & Trends

Gossamer Bio's Amortizatization of Intangibles history runs 8 years deep, the most recent figure standing at $660000.0 for Q1 2026.

  • In Q1 2026, Amortizatization of Intangibles fell 75.25% year-over-year to $660000.0; the TTM figure through Mar 2026 stood at $5.3 million (down 58.44% YoY), while the FY2025 annual figure was $7.3 million, down 44.28% from the prior year.
  • Amortizatization of Intangibles for Q1 2026 stood at $660000.0, down from $1.1 million in the prior quarter.
  • The five-year high for Amortizatization of Intangibles was $3.7 million in Q3 2024, with the low at -$125000.0 in Q1 2022.
  • The 5-year median for Amortizatization of Intangibles is $1.6 million (2025), against an average of $1.9 million.
  • The sharpest annual moves came in 2022 and 2023: Amortizatization of Intangibles slumped 89.39% in 2022, then jumped 7625.0% in 2023.
  • Gossamer Bio's Amortizatization of Intangibles stood at $1.1 million in 2022, then soared by 213.11% to $3.6 million in 2023, then decreased by 6.09% to $3.4 million in 2024, then plunged by 67.84% to $1.1 million in 2025, then sank by 39.0% to $660000.0 in 2026.
  • Business Quant data shows GOSS's Amortizatization of Intangibles at $660000.0 in Q1 2026, $1.1 million in Q4 2025, and $1.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 678,000.00
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Gossamer Bio 49.15 Mn -7.87 Mn - 392,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 392,000.00
Jun 30, 2026 392,000.00
Mar 31, 2026 660,000.00
Mar 31, 2026 660,000.00
Dec 31, 2025 1.08 Mn
Dec 31, 2025 1.08 Mn
Sep 30, 2025 1.59 Mn
Sep 30, 2025 1.59 Mn
Jun 30, 2025 1.94 Mn
Jun 30, 2025 1.94 Mn
Mar 31, 2025 2.67 Mn
Mar 31, 2025 2.67 Mn
Dec 31, 2024 3.36 Mn
Dec 31, 2024 3.36 Mn
Sep 30, 2024 3.66 Mn
Sep 30, 2024 3.66 Mn
Jun 30, 2024 2.99 Mn
Jun 30, 2024 2.99 Mn
Mar 31, 2024 3.05 Mn
Mar 31, 2024 3.05 Mn